Medline revenue and financials
In the fiscal year ended December 2025, Medline reported revenue of $28.43B (+11.47% year over year). Net income was $1.16B, a net margin of 4.1%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +11.47%
- 2025 vs 2024
- Net income growth
- −3.42%
- 2025 vs 2024
- Net margin
- 4.1%
- 2024: 4.7%
How Medline is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 9.9% a year on average over the last 3 years
Compound annual growth rate: from $21.45B in 2022 to $28.43B in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from 4.0% to 7.7%
Operating income over revenue, 2022 → 2025: 3.6 percentage points.
Profits turn into cash: free cash flow equal to 157% of net income
Totals for fiscal years 2023–2025: free cash flow $4.07B, net income $2.59B.
Shares outstanding down 55.7% in 3 years
Average diluted shares, 2022 → 2025: with fewer shares, each one represents a larger stake in the company.
Profitable in 3 of 4 fiscal years
Positive net income, fiscal years 2022–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 28,432 | 25,507 | 23,231 | 21,448 |
| Cost of revenue | 20,914 | 18,531 | 17,346 | 16,231 |
| Gross profit | 7,518 | 6,976 | 5,885 | 5,217 |
| Selling, general and administrative | 4,567 | 4,108 | 3,867 | 3,676 |
| Research and development | 80.0 | 67.0 | 60.0 | — |
| Operating income | 2,179 | 2,148 | 1,411 | 861 |
| EBIT | 2,179 | 2,148 | 1,411 | 861 |
| EBITDA | 3,190 | 3,125 | 2,362 | 1,794 |
| Interest expense | 945 | 1,144 | 1,213 | 899 |
| Pre-tax income | 1,248 | 1,246 | 264 | 10.0 |
| Income tax | 91.0 | 46.0 | 30.0 | 35.0 |
| Net income | 1,159 | 1,200 | 234 | -25.0 |
| Net income to common shareholders | 1,159 | 1,200 | 234 | -25.0 |
| Basic EPS | 1.43 | 0.07 | 0.01 | -0.01 |
| Diluted EPS | 1.43 | 0.07 | 0.01 | -0.01 |
| Average shares (basic) | 810 | 17,467 | 17,500 | 1,828 |
| Average shares (diluted) | 810 | 17,467 | 17,500 | 1,828 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7,685 | 7,352 | 7,787 | 7,115 | 6,886 | 6,644 | 6,784 | 6,388 | 6,185 | 6,168 |
| Cost of revenue | 5,802 | 5,511 | 5,873 | 5,240 | 4,981 | 4,820 | 4,933 | 4,631 | 4,523 | 4,484 |
| Gross profit | 1,883 | 1,841 | 1,914 | 1,875 | 1,905 | 1,824 | 1,851 | 1,757 | 1,662 | 1,684 |
| Selling, general and administrative | 1,295 | 1,228 | 1,265 | 1,116 | 1,086 | 1,089 | 1,164 | 988 | 976 | 978 |
| Operating income | 63.0 | 422 | 443 | 574 | 629 | 552 | 494 | 574 | 516 | 540 |
| EBIT | 63.0 | 422 | 443 | 574 | 629 | 552 | 494 | 574 | 516 | 540 |
| EBITDA | 319 | 676 | 704 | 827 | 879 | 799 | 747 | 822 | 754 | 778 |
| Interest expense | 168 | 165 | 200 | 248 | 253 | 244 | 272 | 286 | 288 | 293 |
| Pre-tax income | 235 | 291 | 206 | 345 | 359 | 338 | 305 | 338 | 300 | 302 |
| Income tax | 96.0 | 52.0 | 26.0 | 23.0 | 26.0 | 16.0 | 16.0 | 14.0 | 8.0 | 8.0 |
| Net income | 60.0 | 129 | 182 | 322 | 333 | 322 | 289 | 324 | 292 | 294 |
| Net income to common shareholders | 59.0 | 138 | 182 | 322 | 333 | 322 | 289 | 324 | 292 | 294 |
| Basic EPS | 0.07 | 0.17 | 0.22 | 0.02 | 0.02 | — | 0.02 | — | — | — |
| Diluted EPS | 0.07 | 0.16 | 0.22 | 0.02 | 0.02 | — | 0.02 | — | — | — |
| Average shares (basic) | 857 | 820 | 810 | 17,480 | 17,502 | — | 17,467 | — | — | — |
| Average shares (diluted) | 861 | 825 | 810 | 17,480 | 17,502 | — | 17,467 | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | 38,484 | 35,978 | 36,122 |
| Current assets | 10,679 | 8,272 | 8,809 |
| Cash and equivalents | 1,939 | 199 | 1,556 |
| Receivables | 3,533 | 3,219 | 2,960 |
| Inventory | 4,769 | 4,456 | 3,813 |
| Net property, plant and equipment | 5,210 | 4,979 | 4,797 |
| Goodwill | 8,079 | 8,065 | 7,532 |
| Other intangible assets | 13,893 | 14,559 | 14,788 |
| Long-term investments | — | 48.0 | 86.0 |
| Current liabilities | 2,490 | 2,440 | 2,131 |
| Accounts payable | 961 | 869 | 696 |
| Long-term debt | 12,484 | 16,416 | 16,446 |
| Total debt | 13,012 | 16,897 | 16,830 |
| Total liabilities | 19,198 | 19,820 | 19,378 |
| Total equity (incl. minority) | 19,286 | 16,158 | 16,744 |
| Retained earnings | -7.0 | 0.0 | — |
| Minority interest | 8,549 | 0.0 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 39,350 | 39,014 | 38,484 | 36,883 | 36,428 | — | 35,978 | — |
| Current assets | 11,742 | 11,180 | 10,679 | 9,558 | 8,947 | — | 8,272 | — |
| Cash and equivalents | 2,327 | 2,236 | 1,939 | 952 | 580 | — | 199 | — |
| Short-term investments | 350 | — | — | — | — | — | — | — |
| Receivables | 3,940 | 3,674 | 3,533 | 3,425 | 3,340 | — | 3,219 | — |
| Inventory | 4,665 | 4,807 | 4,769 | 4,752 | 4,662 | — | 4,456 | — |
| Net property, plant and equipment | 4,697 | 4,758 | 5,210 | 4,690 | 4,672 | — | 4,979 | — |
| Goodwill | 8,072 | 8,076 | 8,079 | 8,069 | 8,069 | — | 8,065 | — |
| Other intangible assets | 13,538 | 13,717 | 13,893 | 14,068 | 14,246 | — | 14,559 | — |
| Long-term investments | — | — | — | 11.0 | 19.0 | — | 48.0 | — |
| Current liabilities | 2,710 | 2,536 | 2,490 | 2,612 | 2,351 | — | 2,440 | — |
| Accounts payable | 1,043 | 932 | 961 | 990 | 919 | — | 869 | — |
| Long-term debt | 12,548 | 12,495 | 12,484 | 16,501 | 16,501 | — | 16,416 | — |
| Total debt | 12,639 | 12,636 | 13,012 | 16,649 | 16,644 | — | 16,897 | — |
| Total liabilities | 20,273 | 19,665 | 19,198 | 20,109 | 19,844 | — | 19,820 | — |
| Total equity (incl. minority) | 19,077 | 19,349 | 19,286 | 16,774 | 16,584 | 16,158 | 16,158 | 16,744 |
| Retained earnings | 182 | 122 | -7.0 | — | — | — | — | — |
| Minority interest | 7,505 | 8,077 | 8,549 | — | — | — | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | 1,744 | 1,769 | 1,685 | 187 |
| Depreciation and amortization | 1,011 | 977 | 951 | 933 |
| Capital expenditure | -480 | -364 | -285 | -254 |
| Investing cash flow | -474 | -1,493 | -312 | -264 |
| Financing cash flow | 399 | -1,613 | -191 | -84.0 |
| Dividends paid | -518 | -1,518 | -114 | -23.0 |
| Share repurchases | -2,003 | -20.0 | 0.0 | — |
| Debt issued | 7,748 | 16,098 | — | 80.0 |
| Debt repaid | -11,840 | -16,161 | -77.0 | -141 |
| Effect of exchange rates | 23.0 | 2.0 | 4.0 | -30.0 |
| Net change in cash | 1,692 | -1,335 | 1,186 | -191 |
| Free cash flow | 1,264 | 1,405 | 1,400 | -67.0 |
| Levered free cash flow | 791 | 760 | — | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 715 | 412 | 229 | 636 | 197 | 682 | -73.0 | 722 | 560 | 560 |
| Depreciation and amortization | 256 | 254 | 261 | 253 | 250 | 247 | 253 | 248 | 238 | 238 |
| Capital expenditure | -111 | -96.0 | -138 | -101 | -143 | -98.0 | -91.0 | -107 | -83.0 | -83.0 |
| Investing cash flow | -461 | -96.0 | -138 | -101 | -143 | -92.0 | -97.0 | -998 | -199 | -199 |
| Financing cash flow | -159 | -13.0 | 897 | -161 | -328 | -9.0 | -1,394 | -558 | 170 | 170 |
| Dividends paid | — | — | -96.0 | -119 | -303 | — | -1,359 | -42.0 | -58.5 | -58.5 |
| Share repurchases | -5.0 | — | -1,970 | -18.0 | -6.0 | -9.0 | -1.0 | -3.0 | -8.0 | -8.0 |
| Debt issued | 4,733 | — | 0.0 | 7,569 | 0.0 | 179 | 6,287 | 2,180 | 3,816 | 3,816 |
| Debt repaid | -4,771 | — | -4,049 | -7,593 | -19.0 | -179 | -6,313 | -2,690 | -3,579 | -3,579 |
| Effect of exchange rates | -4.0 | -7.0 | -1.0 | -3.0 | 18.0 | 9.0 | -2.0 | -2.0 | 3.0 | 3.0 |
| Net change in cash | 91.0 | 296 | 987 | 371 | -256 | 590 | -1,566 | -836 | 534 | 534 |
| Free cash flow | 604 | 316 | 91.0 | 535 | 54.0 | 584 | -164 | 615 | 477 | 477 |
| Levered free cash flow | 215 | 192 | 56.9 | 392 | — | — | — | — | — | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
